Investigation of posaconazole prophylaxis in children with chronic granulomatous disease (CGD): pharmacokinetics and tolerability (iPOD) - iPOD Investigation of posaconazoleprophylaxis in children with chronic granulomatous disease (CGD): pharm ...
Investigation of posaconazole prophylaxis in children with chronic granulomatous disease (CGD): pharmacokinetics and tolerability (iPOD) - iPOD Investigation of posaconazoleprophylaxis in children with chronic granulomatous disease (CGD): pharm ...
Children with chronic granulomatous disease (CGD). MedDRA version: 9.1;Level: LLT;Classification code 10008906;Term: Chronic granulomatous disease Children with chronic granulomatous disease (CGD). MedDRA version: 9.1;Level: LLT;Classification cod ...
Pharmacokinetics of Posaconazole in Children With Chronic Granulomatous Disease (CGD)
Investigation of POsaconazole Prophylaxis in Children With Chronic Granulomatous Disease (CGD): Pharmacokinetics and Tolerability (iPOD) Investigation of POsaconazoleProphylaxis in Children With Chronic Granulomatous Disease (CGD): Pharm ...
Investigation of posaconazole prophylaxis in children with chronic granulomatous disease (CGD): pharmacokinetics and tolerability (iPOD) - iPOD Investigation of posaconazoleprophylaxis in children with chronic granulomatous disease (CGD): pharm ...
Investigation of posaconazole prophylaxis in children with chronic granulomatous disease (CGD): pharmacokinetics and tolerability (iPOD) - iPOD Investigation of posaconazoleprophylaxis in children with chronic granulomatous disease (CGD): pharm ...
Children with chronic granulomatous disease (CGD). MedDRA version: 9.1;Level: LLT;Classification code 10008906;Term: Chronic granulomatous disease Children with chronic granulomatous disease (CGD). MedDRA version: 9.1;Level: LLT;Classification cod ...